For the first time ever, young adults and the parents of children diagnosed with cancer-and the physicians who treat them-have a comprehensive, bilingual resource to give them critically important guidance about preserving their fertility before and during cancer treatment...
Nuffield Health Cambridge Hospital Leads The Way In Cancer Care, UK
6/20/2011
Nuffield Health Cambridge Hospital has been awarded the Macmillan Quality Environment Mark for its cancer-care facilities...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate. Basal cell carcinoma is a form of skin cancer that can cause disfiguring and debilitating effects and can ultimately be life-threatening...
University To Develop Skin Cancer Detection Tool To Save Lives
6/20/2011
Hundreds of lives could be saved thanks to a new tool being developed at De Montfort University (DMU) that could help improve the early detection of skin cancer...
Photocure Initiates Enrolment Into Phase II Trial Of Cevira(R) For Cervical HPV Infection
6/20/2011
Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology, has initiated patient enrolment in the first trial to evaluate the optimal dose and safety of Cevira, a novel integrated intravaginal drug-delivery device...
In Early Studies, New Approach To Cancer Vaccines Proves Successful
6/20/2011
University of Leeds researchers, funded by Cancer Research UK, have used a library of DNA to create a vaccine that could be used to treat cancer, according to a study published in Nature Medicine. Before now, 'gene therapy' vaccines have often delivered just one gene to stimulate the immune system...
Study Of Biomarker Development In Mice Provides A Roadmap For A Similar Approach In Humans
6/20/2011
Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans. The findings, by principal investigator Amanda Paulovich, M.D., Ph.D...
Completely New Approach To Cancer Vaccines Proves Succesful In Early Studies
6/20/2011
Cancer Research UK scientists at the University of Leeds have used a library of DNA to create a vaccine that could be used to treat cancer, according to a study published in Nature Medicine. Before now, 'gene therapy' vaccines have often delivered just one gene to stimulate the immune system. It produces a protein, called an antigen, which activates the immune system to destroy cancer cells...
Breast Cancer Patients Mustn't Ignore Heart Disease Risk
6/20/2011
New research shows large numbers of older women diagnosed with breast cancer died from something other than the cancer, with heart and circulatory disease being the leading cause of death...
Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Celgene International Sarl (Nasdaq: CELG) today announced a collaboration to conduct an international randomized study to evaluate the therapeutic potential of the REVLIMID (lenalidomide)/rituximab combination regimen (R2) in patients with newly diagnosed follicular lymphoma (FL). The RELEVANCE Study (Rituximab and Lenalidomide vs...